Management of Bell's Palsy: A Report of 2 Cases by ARAUJO, Melissa Rodrigues de et al.
	 JCDA	•	www.cda-adc.ca/jcda • November 2008, Vol. 74, No. 9 • 823
Clinical
p r a c t i c E
	Contact	Author
Management of Bell’s Palsy: A Report of 2 Cases 
Melissa Rodrigues de Araujo, DDS, MSc; Marcelo Rodrigues Azenha, DDS;  
Marcos Maurício Capelari, DDS; Clovis Marzola, DDS, MSc, PhD
ABSTRACT
Bell’s palsy is a neuropathy of the peripheral seventh cranial nerve, resulting from trau-
matic, compressive, infective, inflammatory or metabolic abnormalities or it can be 
idiopathic. HIV, Epstein-Barr virus and hepatitis B virus have been suspected as initi-
ating organisms, but herpes simplex virus is the most frequently implicated. This report 
describes 2 cases of Bell’s palsy in children that were managed with antiviral agents. 
Both patients experienced complete recovery within 28 days; after 1 year follow-up, no 
recurrence was observed and both patients have normal facial movement. Differential 
diagnosis is essential to guide the treatment plan in Bell’s palsy. Special attention should 
be given to children with respect to prescription of medications that can cause important 
side effects.
Bell’s palsy is a neuropathy of the pe-ripheral seventh cranial nerve, usually resulting from traumatic, compressive, 
infective, inflammatory or metabolic abnor-
malities. However, in many cases no etiology 
is identified and the eventual diagnosis is 
idiopathic.1 
The condition is named after Dr. Charles 
Bell, who, in 1821, described complete facial 
paralysis after injury of the stylomastoid fo-
ramen.2 Bell’s palsy can be defined as acute 
peripheral facial nerve palsy usually of un-
known cause.3 It is typically unilateral and 
can be complete or partial.4 Although there 
is agreement on the definition, there is no 
consensus regarding the etiology, diagnostic 
approach or management of this enigmatic 
condition.5
Bell’s palsy is generally a unilateral dis-
ease, affecting both sides of the face equally.1,5 
The pathogenesis of Bell’s palsy remains con-
troversial. Acute inflammation and edema of 
the facial nerve are thought to lead to entrap-
ment of the nerve in the bony canal (especially 
in the labyrinthine segment), which leads to 
compression and ischemia.6,7 
An inflammatory process surrounds the 
nerve fibres. Many viruses, such as HIV,8 
Epstein-Barr virus9 and hepatitis B virus10 
have been suspected in initiating this inflam-
mation, but herpes simplex virus (HSV) is the 
most frequently implicated.11,12 
Increasing evidence is associating HSV 
with Bell’s palsy, and, in time, Bell’s palsy may 
well be reclassified as an HSV mononeuritis of 
the facial nerve, although designation of this 
causative agent does not exclude the possi-
bility that other causes may exist or negate the 
role that entrapment plays in the degeneration 
of the nerve. According to one hypothesis, 
HSV, dormant in the geniculate ganglion cells, 
becomes reactivated and replicates, causing 
inflammation, primarily in the geniculate 
ganglion and in the labyrinthine segment of 
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the facial nerve. These inflammatory events (evident on 
magnetic resonance imaging) result in entrapment and 
ischemia, which lead to neurapraxia or degeneration of 
the facial nerve distal to the meatal foramen.13
HSV has been identified in the endoneural fluid, pos-
terior auricular muscle and saliva by polymerase chain 
reaction in patients with Bell’s palsy.11 Increased capillary 
permeability leads to exudation of fluid, edema and com-
pression of the microcirculation of the nerve, which may 
be responsible for the vascular ischemia.4
Patients generally experience rapid onset of unilateral 
facial palsy and often describe numbness or stiffness, al-
though no actual sensory loss occurs.5,7 Affected patients 
are usually unable to close their eyes. Facial appearance 
becomes asymmetric, and saliva dribbles down the angle 
of the mouth. Depending on the site of the lesion, some 
patients may complain of noise intolerance or loss of 
taste sensation.1,5 A focused physical examination can 
help rule out other conditions and narrow the differential 
diagnosis.7
Treatment of Bell’s palsy is controversial, because as 
many as two-thirds of patients recover spontaneously. 
Corticosteroids alone or associated with antiviral agents 
have been recommended.7 Adour14 reported that patients 
with Bell’s palsy treated with acyclovir and prednisone 
experience a more favourable recovery and less neural de-
generation than patients treated with placebo plus pred-
nisone. The favourable response to the treatment of Bell’s 
palsy with acyclovir–prednisone supports the theory that 
reactivated HSV causes a neuritis.
Case	Reports
Case 1
A 12-year-old girl with left hemifacial palsy over the 
past 15 days was referred to the oral and maxillofacial 
surgery department at Hospital de Base, Bauru, São Paulo, 
Brazil, by her pediatrician. She denied any type of facial 
trauma or systemic alteration. Although no diagnosis 
was made by the doctor, an antibiotic was prescribed and 
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Figure	1:	Facial aspect of patient in case 1, showing Bell’s palsy on the left side. (a) Inability to smile. (b) Incomplete left eye closure. 
(c) No movement in the upper left eyebrow. (d) Absence of movement in the left portion of the labial orbicular muscle.
Figure	2: Facial aspect of patient in case 1 after recovery of facial movement. (a) Normal, symmetric smile. (b) Complete closure of the 
left eye. (c) Normal left eyebrow movement. (d) Normal movement of labial orbicular muscle.
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she had been taking it for the last 7 days without any im-
provement. Her mother reported that the girl had been at 
a school camp for 2 weeks before the first signs of palsy, 
severe headache, dizziness and fever. A friend of the girl 
had exhibited the same signs and symptoms after the 
camping trip. 
Clinical examination revealed restricted movement 
of both the superior and inferior lips and in the left su-
perior palpebra and left eyebrow region, associated with 
moderate pain around the left ear (Fig. 1). The patient 
was diagnosed with hemifacial Bell’s palsy caused by 
a viral infection, although no HSV or herpes zoster le-
sions were present. She was prescribed acyclovir, 200 mg, 
every 4 hours, vitamin B complex every 12 hours and 
artificial tears during the day. She was advised to start 
facial physiotherapy exercises combined with warm water 
compresses and to keep the left eye closed with tape or a 
sleep mask during the night to avoid conjunctive dryness. 
After 28 days of medication, the facial palsy disappeared. 
The patient was seen weekly during the first month, then 
monthly for 1 year, and no signs of recurrence were noted 
(Fig. 2).
Case	2
An 11-year-old girl, who was the roommate of the 
patient described above during the school camping 
vacation, exhibited left hemifacial palsy that had been 
detected 6 days before her first appointment. She de-
scribed severe pain about 10 mm anterior to her left ear, 
just above the facial nerve trajectory. During facial exam-
ination, the patient demonstrated an inability to close 
the right eye, to corrugate the left eyebrow or to move 
her lips (Fig. 3). The patient was prescribed acyclovir, 
200 mg every 4 hours and vitamin B complex every 
12 hours for 28 days and artificial tears during the day. 
The patient recovered normal facial function, and after 
1 year of follow-up, facial movements were satisfactory. 
Discussion
Many pathologies can be included in the differential 
diagnosis of Bell’s palsy: unilateral central facial weak-
ness, Ramsay Hunt syndrome, Lyme neuroborreliosis, tu-
mours, diabetes mellitus, sarcoidosis, weight loss, visual 
changes, vertigo and weakness or numbness.7
Diagnosis of Bell’s palsy depends on clinical signs, 
symptoms and evaluation to exclude other possible causes 
of facial paralysis.
Laboratory investigations and imaging are carried out 
to detect the origin of the paralysis: lumbar puncture, 
IgG and IgM antibody tests and cerebral spinal fluid cell 
count to detect intracranial pressure and inflammation; 
magnetic resonance imaging and computed tomography 
to locate an intracranial lesion or hemorrhage; Lyme titre 
test to rule out Lyme disease; and acetylcholine-receptor 
antibody test for myasthenia gravis.15 
IgG and IgM antibody titres were not available for 
our patients because of the cost and lack of resources. 
Because no specific laboratory test confirms the diagnosis 
of Bell’s palsy, its assessment remains clinical. Thus, even 
with IgG and IgM antibody tests, our clinical approach 
would have been the same. It is important to emphasize 
the fact that we followed these patients weekly and noted 
that they were recovering very well.
Patients should be advised to use artificial tears to keep 
the eyes moist and prevent exposure keratitis. During the 
day, sunglasses are indicated, and dirty, noxious fumes 
should be avoided. During sleep, an ophthalmic ointment 
should be used.7 
Our patients enjoyed complete recovery after 4 weeks, 
but clinicians should be aware of possible morbidities. 
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Figure	3:	Signs of hemifacial Bell’s palsy in case 2. (a) Incomplete smile. (b) Inability to close the right eye. (c) Right eyebrow movement 
compromised. (d) Incomplete right labial movement.
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For example, some patients experience lasting facial 
weakness. Factors associated with a poor prognosis in-
clude advanced age, hypertension and impairment of 
taste and pain other than in the ear. Bell’s palsy does not 
usually recur; however, if it does, particularly bilaterally, 
further investigation is required to rule out other causes 
of facial paralysis such as myasthenia gravis, sarcoidosis 
and lymphoma.3
Patients who have persistent clinical signs without 
improvement in facial paresis after 4 weeks, involve-
ment of other cranial nerves or a second episode of palsy 
require further investigation.7 A detailed history and 
thorough clinical examination should be carried out in 
those patients. Early recognition of signs and symptoms 
inconsistent with Bell’s palsy is important to avoid mis-
diagnosis. If the patient does not recover within the ex-
pected timeframe, imaging must be performed, such as 
computed tomography or magnetic resonance imaging. 
Current imaging techniques may reveal occult lesions of 
the temporal bone, internal acoustic canal or cerebello-
pontine angle, for example.16
Many clinical trials have evaluated acyclovir with 
or without prednisone for the treatment of Bell’s palsy: 
Adour4 and De Diego,17 for example, using a facial par-
alysis recovery profile. Studies evaluating the efficacy of 
antiviral agents for the treatment of Bell’s palsy show 
conflicting results. As each trial has used different treat-
ment modalities, facial nerve recovery scales and doses of 
acyclovir, and some have involved only a small number of 
patients, it is difficult to compare their results and verify 
the effectiveness of acyclovir.3
Although many studies have examined the usefulness 
of corticosteroids in the treatment of Bell’s palsy, they 
have been limited by small sample size and lack of ran-
domization, controls and blinding. Considerable contro-
versy remains over the use of steroids for Bell’s palsy in 
adults, and there is even less evidence for using steroids 
to treat Bell’s palsy in children.18 Children are more vul-
nerable to the side effects of corticosteroids, particularly 
their effect on growth, immunity and adrenal suppres-
sion. A side effect of corticosteroids unique to children is 
growth suppression, which can be reduced by prescribing 
the medication on alternate days.19 
Boulloche and others20 carried out a retrospective re-
view of 40 patients aged 1–16 years with acute facial nerve 
palsy. Patients who received steroids did not have better 
outcomes than those who did not receive steroids; similar 
findings were revealed by Dhiravibulya.21 Given the nat-
ural history of spontaneous recovery in most pediatric 
patients, steroid therapy is currently not indicated.18 In 
the cases described above, we preferred to avoid steroids 
and prescribe antiviral agents associated with vitamin B. 
Differential diagnosis is essential to guide treatment 
in Bell’s palsy. Although its etiology is still unknown, 
viral infection, vascular ischemia and autoimmune dis-
orders have all been postulated as possible mechanisms. 
Special attention should be given to children with respect 
to steroid prescription. Dentists, especially those who 
deal with children, should be aware of this disorder. a
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